These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28105479)

  • 1. From cells to QSAR: Alternative predictive models in toxicology.
    Sambuy Y; Bassi AM; Scanarotti C; Caloni F
    ALTEX; 2017; 34(1):168-171. PubMed ID: 28105479
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive toxicology today: the transition from biological knowledge to practicable models.
    Benigni R
    Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):989-92. PubMed ID: 27351633
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro methodologies for enhanced toxicity testing.
    DelRaso NJ
    Toxicol Lett; 1993 May; 68(1-2):91-9. PubMed ID: 8516778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The principles and practice of toxigenomics: applications and opportunities.
    Pennie WD; Tugwood JD; Oliver GJ; Kimber I
    Toxicol Sci; 2000 Apr; 54(2):277-83. PubMed ID: 10774809
    [No Abstract]   [Full Text] [Related]  

  • 5. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing.
    Kroeger M
    Trends Biotechnol; 2006 Aug; 24(8):343-6. PubMed ID: 16782220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro toxicology in the light of new technologies.
    Fry J; George E
    Altern Lab Anim; 2001; 29(6):745-8. PubMed ID: 11764747
    [No Abstract]   [Full Text] [Related]  

  • 7. In silico methods for early toxicity assessment.
    Merlot C
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):80-5. PubMed ID: 18175270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charting a course for cell culture alternatives to animal testing.
    Goldberg L
    Fundam Appl Toxicol; 1986 May; 6(4):607-17. PubMed ID: 3519344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer-modeling-based QSARs for analyzing experimental data on biotransformation and toxicity.
    Soffers AE; Boersma MG; Vaes WH; Vervoort J; Tyrakowska B; Hermens JL; Rietjens IM
    Toxicol In Vitro; 2001; 15(4-5):539-51. PubMed ID: 11566589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternatives to in vivo tests for teratologic screening.
    Prati M; Giavini E; Menegola E
    Ann Ist Super Sanita; 1993; 29(1):41-6. PubMed ID: 8129271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative approach for the safety evaluation of new and existing chemicals, an exercise in integrated testing.
    Gubbels-van Hal WM; Blaauboer BJ; Barentsen HM; Hoitink MA; Meerts IA; van der Hoeven JC
    Regul Toxicol Pharmacol; 2005 Aug; 42(3):284-95. PubMed ID: 15979772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How not to develop a quantitative structure-activity or structure-property relationship (QSAR/QSPR).
    Dearden JC; Cronin MT; Kaiser KL
    SAR QSAR Environ Res; 2009; 20(3-4):241-66. PubMed ID: 19544191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro methods and their use in toxicology].
    Hurná E
    Vet Med (Praha); 1997 Jul; 42(7):213-5. PubMed ID: 9304279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity tests in animals: alternative models.
    Sklarew M
    Environ Health Perspect; 1993 Sep; 101(4):288-91. PubMed ID: 8275982
    [No Abstract]   [Full Text] [Related]  

  • 15. [Animal toxicology studies necessary for clinical research and the registry of drugs for human use: conclusions of the International Conference of Harmonization (and II)].
    Tristán C; Galende I; Rubio Terrés C; Duque I
    Med Clin (Barc); 1994 May; 102(20):791-6. PubMed ID: 7913735
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction, expression and maintenance of cytochrome P450 isoforms in long-term cultures of primary human hepatocytes.
    Yuan J; Liu L; Shimada M; Wang A; Ruhnke M; Heeckt P; Muller AR; Nussler NC; Neuhaus P; Nussler A
    ALTEX; 2004; 21 Suppl 3():3-11. PubMed ID: 15057403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the nature, evolution and future of quantitative structure-activity relationships (QSAR) in toxicology.
    Veith GD
    SAR QSAR Environ Res; 2004; 15(5-6):323-30. PubMed ID: 15669692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictivity of the -alert performance- functionality of the OECD QSAR-Toolbox (c/w further issues on the predictivity of nonclinical testing).
    Suarez-Torres JD; Ciangherotti CE; Jimenez-Orozco FA
    Toxicol In Vitro; 2020 Aug; 66():104858. PubMed ID: 32278032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priorities in the development of alternative methodologies in the pharmaceutical industry.
    Jackson MR
    Arch Toxicol Suppl; 1998; 20():61-70. PubMed ID: 9442282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of alternative methodologies in toxicology.
    Gribaldo L
    Curr Protoc Toxicol; 2007 Nov; Chapter 20():Unit20.1. PubMed ID: 20882519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.